Infectious Diseases Diagnostics Market by Product (Instrument, Kits and reagents, Consumables)
Industry: Healthcare
Published Date: March-2023
Format: PPT*, PDF, EXCEL
Delivery Timelines: Contact Sales
Number of Pages: 241
Report ID: PMRREP11413
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
4. Key Success Factors
4.1. Production Adoption Analysis
4.2. Regulatory Scenario
4.3. Reimbursement Landscape
4.4. Supply Chain Analysis
4.5. PESTEL Analysis
4.6. Porter’s Analysis
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP Growth Outlook
5.1.2. Global Healthcare Outlook
5.1.3. Parent Market Outlook
5.2. Forecast Factors - Relevance & Impact
5.2.1. Development of Novel Products
5.2.2. Regulatory Imposition
5.2.3. Increasing Demand for Rapid Diagnostic Kits
5.2.4. Increasing Production Launches
5.2.5. Growing Government Investment
5.2.6. Strategic Mergers and Acquisitions Among Local
5.2.7. High Demand for PoC Testing
5.2.8. Rising Awareness about Early Testing
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. COVID-19 Crisis Analysis
6.1. COVID-19 and Impact Analysis
6.1.1. By Product
6.1.2. By Test Type
6.1.3. By Application
6.1.4. By End User
6.1.5. By Region
6.2. 2022 Market Scenario
7. Global Infectious Disease Diagnostic Market Demand (in Value US$ Mn) Analysis 2013–2022 and Forecast, 2023-2033
7.1. Historical Market Value (US$ Mn) Analysis, 2013–2022
7.2. Current and Future Market Value (US$ Mn) Projections, 2023-2033
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Global Infectious Disease Diagnostic Market Analysis 2013–2022 and Forecast 2023-2033, By Product
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) Analysis, by Product, 2013–2022
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, by Product, 2023-2033
8.4. Instrument
8.4.1. Biochips
8.4.2. Microfluidics Based POCT
8.4.3. DNA Microarrays
8.4.4. Mass Spectrometry
8.4.5. Real-time Polymerase Chain Reaction (qPCR)
8.4.6. Fluorescence in situ Hybridization (FISH)
8.4.7. Sequencing
8.4.8. Capillary Electrophoresis
8.4.9. Next Generation Sequencing
8.5. Kits and reagents
8.5.1. Kits
8.5.2. Primary antibodies
8.5.3. Secondary antibodies
8.5.4. Substrates
8.5.5. Buffers
8.6. consumables
8.7. Market Attractiveness Analysis, by Product
9. Global Infectious Disease Diagnostic Market Analysis 2013–2022 and Forecast 2023-2033, By Test Type
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) Analysis, By Test Type, 2013–2022
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, by Test Type, 2023-2033
9.3.1. Screening Test
9.3.2. Diagnostic Test
9.4. Market Attractiveness Analysis, by Test Type
10. Global Infectious Disease Diagnostic Market Analysis 2013–2022 and Forecast 2023-2033, By Application
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) Analysis, By Test Type, 2013–2022
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, by Application, 2023-2033
10.3.1. Hospital- Acquired Infections
10.3.2. Sexually Transmitted Disease (STD)
10.3.3. Sepsis
10.3.4. Meningitis
10.3.5. Respiratory Infections
10.3.6. HPV
10.3.7. Gastrointestinal Tract Infections
10.3.8. Infection in Transplant Patients
10.3.9. Hepatitis B and C
10.3.10. Tuberculosis
10.3.11. Others
10.4. Market Attractiveness Analysis, by Application
11. Global Infectious Disease Diagnostic Market Analysis 2013–2022 and Forecast 2023-2033, By End User
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn) Analysis, By End User, 2013–2022
11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, by End User, 2023-2033
11.3.1. Hospitals
11.3.2. Diagnostic Laboratories
11.3.3. Clinics
11.3.4. Academic and Research Institutes
11.3.5. Others
Market Attractiveness Analysis, by End User
12. Global Infectious Disease Diagnostic Market Analysis 2013–2022 and Forecast 2023-2033, By Region
12.1. Introduction
12.2. Historical Market Size (US$ Mn) Analysis, by Region, 2013–2022
12.3. Current and Future Market Value (US$ Mn) Analysis and Forecast, By Region, 2023-2033
12.3.1. North America
12.3.2. Latin America
12.3.3. Europe
12.3.4. East Asia
12.3.5. South Asia
12.3.6. Oceania
12.3.7. Middle East and Africa (MEA)
12.4. Market Attractiveness Analysis, by Region
13. North America Infectious Disease Diagnostic Market Analysis 2013–2022 and Forecast 2023-2033
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Analysis, by Market Taxonomy, 2013–2022
13.3. Current and Future Market Value (US$ Mn) Analysis and Forecast, by Market Taxonomy, 2023-2033
13.3.1. By Country
13.3.1.1. U.S.
13.3.1.2. Canada
13.3.2. By Product
13.3.3. By Test Type
13.3.4. By Application
13.3.5. By End User
13.4. Market Attractiveness Analysis
13.4.1. By Country
13.4.2. By Product
13.4.3. By Test Type
13.4.4. By Application
13.4.5. By End User
13.5. Market Trends
13.6. Key Market Participants – Intensity Mapping
13.7. Drivers and Restraints - Impact Analysis
13.8. Country Level Analysis & Forecast
13.8.1. U.S. Infectious Disease Diagnostic Market Analysis
13.8.1.1. Introduction
13.8.1.2. Market Analysis and Forecast, by Market Taxonomy
13.8.1.2.1. By Product
13.8.1.2.2. By Test Type
13.8.1.2.3. By Application
13.8.1.2.4. By End User
13.8.2. Canada Infectious Disease Diagnostic Market Analysis
13.8.2.1. Introduction
13.8.2.2. Market Analysis and Forecast, by Market Taxonomy
13.8.2.2.1. By Product
13.8.2.2.2. By Test Type
13.8.2.2.3. By Application
13.8.2.2.4. By End User
14. Latin America Infectious Disease Diagnostic Market Analysis 2013–2022 and Forecast 2023-2033
14.1. Introduction
14.2. Historical Market Size (US$ Mn) Analysis, by Market Taxonomy, 2013–2022
14.3. Current and Future Market Value (US$ Mn) Analysis and Forecast, by Market Taxonomy, 2023-2033
14.3.1. By Country
14.3.1.1. Mexico
14.3.1.2. Brazil
14.3.1.3. Argentina
14.3.1.4. Rest of Latin America
14.3.2. By Product
14.3.3. By Test Type
14.3.4. By Application
14.3.5. By End User
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Product
14.4.3. By Test Type
14.4.4. By Application
14.4.5. By End User
14.5. Market Trends
14.6. Key Market Participants – Intensity Mapping
14.7. Drivers and Restraints - Impact Analysis
14.8. Country Level Analysis & Forecast
14.8.1. Mexico Infectious Disease Diagnostic Market Analysis
14.8.1.1. Introduction
14.8.1.2. Market Analysis and Forecast, by Market Taxonomy
14.8.1.2.1. By Product
14.8.1.2.2. By Test Type
14.8.1.2.3. By Application
14.8.1.2.4. By End User
14.8.2. Brazil Infectious Disease Diagnostic Market Analysis
14.8.2.1. Introduction
14.8.2.2. Market Analysis and Forecast, by Market Taxonomy
14.8.2.2.1. By Product
14.8.2.2.2. By Test Type
14.8.2.2.3. By Application
14.8.2.2.4. By End User
14.8.3. Argentina Infectious Disease Diagnostic Market Analysis
14.8.3.1. Introduction
14.8.3.2. Market Analysis and Forecast, by Market Taxonomy
14.8.3.2.1. By Product
14.8.3.2.2. By Test Type
14.8.3.2.3. By Application
14.8.3.2.4. By End User
15. Europe Infectious Disease Diagnostic Market Analysis 2013–2022 and Forecast 2023-2033
15.1. Introduction
15.2. Historical Market Size (US$ Mn) Analysis, by Market Taxonomy, 2013–2022
15.3. Current and Future Market Value (US$ Mn) Analysis and Forecast, by Market Taxonomy, 2023-2033
15.3.1. By Country
15.3.1.1. Germany
15.3.1.2. Italy
15.3.1.3. France
15.3.1.4. U.K.
15.3.1.5. Spain
15.3.1.6. BENELUX
15.3.1.7. Russia
15.3.1.8. Rest of Europe
15.3.2. By Product
15.3.3. By Test Type
15.3.4. By Application
15.3.5. By End User
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Product
15.4.3. By Test Type
15.4.4. By Application
15.4.5. By End User
15.5. Market Trends
15.6. Key Market Participants – Intensity Mapping
15.7. Drivers and Restraints - Impact Analysis
15.8. Country Level Analysis & Forecast
15.8.1. Germany Infectious Disease Diagnostic Market Analysis
15.8.1.1. Introduction
15.8.1.2. Market Analysis and Forecast, by Market Taxonomy
15.8.1.2.1. By Product
15.8.1.2.2. By Test Type
15.8.1.2.3. By Application
15.8.1.2.4. By End User
15.8.2. Italy Infectious Disease Diagnostic Market Analysis
15.8.2.1. Introduction
15.8.2.2. Market Analysis and Forecast, by Market Taxonomy
15.8.2.2.1. By Product
15.8.2.2.2. By Test Type
15.8.2.2.3. By Application
15.8.2.2.4. By End User
15.8.3. France Infectious Disease Diagnostic Market Analysis
15.8.3.1. Introduction
15.8.3.2. Market Analysis and Forecast, by Market Taxonomy
15.8.3.2.1. By Product
15.8.3.2.2. By Test Type
15.8.3.2.3. By Application
15.8.3.2.4. By End User
15.8.4. U.K. Infectious Disease Diagnostic Market Analysis
15.8.4.1. Introduction
15.8.4.2. Market Analysis and Forecast, by Market Taxonomy
15.8.4.2.1. By Product
15.8.4.2.2. By Test Type
15.8.4.2.3. By Application
15.8.4.2.4. By End User
15.8.5. Spain Infectious Disease Diagnostic Market Analysis
15.8.5.1. Introduction
15.8.5.2. Market Analysis and Forecast, by Market Taxonomy
15.8.5.2.1. By Product
15.8.5.2.2. By Test Type
15.8.5.2.3. By Application
15.8.5.2.4. By End User
15.8.6. BENELUX Infectious Disease Diagnostic Market Analysis
15.8.6.1. Introduction
15.8.6.2. Market Analysis and Forecast, by Market Taxonomy
15.8.6.2.1. By Product
15.8.6.2.2. By Test Type
15.8.6.2.3. By Application
15.8.6.2.4. By End User
15.8.7. Russia Infectious Disease Diagnostic Market Analysis
15.8.7.1. Introduction
15.8.7.2. Market Analysis and Forecast, by Market Taxonomy
15.8.7.2.1. By Product
15.8.7.2.2. By Test Type
15.8.7.2.3. By Application
15.8.7.2.4. By End User
16. East Asia Infectious Disease Diagnostic Market Analysis 2013–2022 and Forecast 2023-2033
16.1. Introduction
16.2. Historical Market End User (US$ Mn) Analysis, by Market Taxonomy, 2013–2022
16.3. Current and Future Market Value (US$ Mn) Analysis and Forecast, by Market Taxonomy, 2023-2033
16.3.1. By Country
16.3.1.1. China
16.3.1.2. Japan
16.3.1.3. South Korea
16.3.2. By Product
16.3.3. By Test Type
16.3.4. By Application
16.3.5. By End User
16.4. Market Attractiveness Analysis
16.4.1. By Product
16.4.2. By Test Type
16.4.3. By Application
16.4.4. By End User
16.5. Market Trends
16.6. Key Market Participants – Intensity Mapping
16.7. Drivers and Restraints - Impact Analysis
16.8. Country Level Analysis & Forecast
16.8.1. China Infectious Disease Diagnostic Market Analysis
16.8.1.1. Introduction
16.8.1.2. Market Analysis and Forecast, by Market Taxonomy
16.8.1.2.1. By Product
16.8.1.2.2. By Test Type
16.8.1.2.3. By Application
16.8.1.2.4. By End User
16.8.2. Japan Infectious Disease Diagnostic Market Analysis
16.8.2.1. Introduction
16.8.2.2. Market Analysis and Forecast, by Market Taxonomy
16.8.2.2.1. By Product
16.8.2.2.2. By Test Type
16.8.2.2.3. By Application
16.8.2.2.4. By End User
16.8.3. South Korea Infectious Disease Diagnostic Market Analysis
16.8.3.1. Introduction
16.8.3.2. Market Analysis and Forecast, by Market Taxonomy
16.8.3.2.1. By Product
16.8.3.2.2. By Test Type
16.8.3.2.3. By Application
16.8.3.2.4. By End User
17. South Asia Infectious Disease Diagnostic Market Analysis 2013–2022 and Forecast 2023-2033
17.1. Introduction
17.2. Historical Market Size (US$ Mn) Analysis, by Market Taxonomy, 2013–2022
17.3. Current and Future Market Value (US$ Mn) Analysis and Forecast, by Market Taxonomy, 2023-2033
17.3.1. By Country
17.3.1.1. India
17.3.1.2. Indonesia
17.3.1.3. Malaysia
17.3.1.4. Thailand
17.3.1.5. Rest of South Asia
17.3.2. By Product
17.3.3. By Test Type
17.3.4. By Application
17.3.5. By End User
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Product
17.4.3. By Test Type
17.4.4. By Application
17.4.5. By End User
17.5. Market Trends
17.6. Key Market Participants – Intensity Mapping
17.7. Drivers and Restraints - Impact Analysis
17.8. Country Level Analysis & Forecast
17.8.1. India Infectious Disease Diagnostic Market Analysis
17.8.1.1. Introduction
17.8.1.2. Market Analysis and Forecast, by Market Taxonomy
17.8.1.2.1. By Product
17.8.1.2.2. By Test Type
17.8.1.2.3. By Application
17.8.1.2.4. By End User
17.8.2. Indonesia Infectious Disease Diagnostic Market Analysis
17.8.2.1. Introduction
17.8.2.2. Market Analysis and Forecast, by Market Taxonomy
17.8.2.2.1. By Product
17.8.2.2.2. By Test Type
17.8.2.2.3. By Application
17.8.2.2.4. By End User
17.8.3. Malaysia Infectious Disease Diagnostic Market Analysis
17.8.3.1. Introduction
17.8.3.2. Market Analysis and Forecast, by Market Taxonomy
17.8.3.2.1. By Product
17.8.3.2.2. By Test Type
17.8.3.2.3. By Application
17.8.3.2.4. By End User
17.8.4. Thailand Infectious Disease Diagnostic Market Analysis
17.8.4.1. Introduction
17.8.4.2. Market Analysis and Forecast, by Market Taxonomy
17.8.4.2.1. By Product
17.8.4.2.2. By Test Type
17.8.4.2.3. By Application
17.8.4.2.4. By End User
18. Oceania Infectious Disease Diagnostic Market 2012-2022 and Forecast 2022-2033
18.1. Introduction
18.2. Historical Market Size (US$ Mn) Analysis, by Market Taxonomy, 2013–2022
18.3. Current and Future Market Value (US$ Mn) Analysis and Forecast, by Market Taxonomy, 2023-2033
18.3.1. By Country
18.3.1.1. Australia
18.3.1.2. New Zealand
18.3.2. By Product
18.3.3. By Test Type
18.3.4. By Application
18.3.5. By End User
18.4. Market Attractiveness Analysis
18.4.1. By Country
18.4.2. By Product
18.4.3. By Test Type
18.4.4. By Application
18.4.5. By End User
18.5. Key Market Participants - Intensity Mapping
18.6. Key Market Participants – Intensity Mapping
18.7. Drivers and Restraints - Impact Analysis
18.8. Country Level Analysis & Forecast
18.8.1. Australia Infectious Disease Diagnostic Market Analysis
18.8.1.1. Introduction
18.8.1.2. Market Analysis and Forecast, by Market Taxonomy
18.8.1.2.1. By Product
18.8.1.2.2. By Test Type
18.8.1.2.3. By Application
18.8.1.2.4. By End User
18.8.2. New Zealand Infectious Disease Diagnostic Market Analysis
18.8.2.1. Introduction
18.8.2.2. Market Analysis and Forecast, by Market Taxonomy
18.8.2.2.1. By Product
18.8.2.2.2. By Test Type
18.8.2.2.3. By Application
18.8.2.2.4. By End User
19. Middle East and Africa (MEA) Infectious Disease Diagnostic Market Analysis 2013–2022 and Forecast 2023-2033
19.1. Introduction
19.2. Historical Market Size (US$ Mn) Analysis, by Market Taxonomy, 2013–2022
19.3. Current and Future Market Value (US$ Mn) Analysis and Forecast, by Market Taxonomy, 2023-2033
19.3.1. By Country
19.3.1.1. GCC Countries
19.3.1.2. Türkiye
19.3.1.3. South Africa
19.3.1.4. North Africa
19.3.1.5. Rest of Middle East and Africa
19.3.2. By Product
19.3.3. By Test Type
19.3.4. By Application
19.3.5. By End User
19.4. Market Attractiveness Analysis
19.4.1. By Product
19.4.2. By Test Type
19.4.3. By Application
19.4.4. By End User
19.5. Market Trends
19.6. Key Market Participants – Intensity Mapping
19.7. Drivers and Restraints - Impact Analysis
19.8. Country Level Analysis & Forecast
19.8.1. GCC Countries Infectious Disease Diagnostic Market Analysis
19.8.1.1. Introduction
19.8.1.2. Market Analysis and Forecast, by Market Taxonomy
19.8.1.2.1. By Product
19.8.1.2.2. By Test Type
19.8.1.2.3. By Application
19.8.1.2.4. By End User
19.8.2. Türkiye Infectious Disease Diagnostic Market Analysis
19.8.2.1. Introduction
19.8.2.2. Market Analysis and Forecast, by Market Taxonomy
19.8.2.2.1. By Product
19.8.2.2.2. By Test Type
19.8.2.2.3. By Application
19.8.2.2.4. By End User
19.8.3. South Africa Infectious Disease Diagnostic Market Analysis
19.8.3.1. Introduction
19.8.3.2. Market Analysis and Forecast, by Market Taxonomy
19.8.3.2.1. By Product
19.8.3.2.2. By Test Type
19.8.3.2.3. By Application
19.8.3.2.4. By End User
19.8.4. North Africa Infectious Disease Diagnostic Market Analysis
19.8.4.1. Introduction
19.8.4.2. Market Analysis and Forecast, by Market Taxonomy
19.8.4.2.1. By Product
19.8.4.2.2. By Test Type
19.8.4.2.3. By Application
19.8.4.2.4. By End User
20. Market Structure Analysis
20.1. Market Analysis, by Tier of Companies
20.2. Market Share Analysis of Top Players
20.3. Market Presence Analysis
21. Competition Analysis
21.1. Competition Dashboard
21.2. Competition Benchmarking
21.3. Competition Deep Dive
21.3.1. Affymetrix, Inc.
21.3.1.1. Overview
21.3.1.2. Product Portfolio
21.3.1.3. Sales Footprint
21.3.1.4. Key Financials
21.3.1.5. SWOT Analysis
21.3.1.6. Strategy Overview
21.3.1.6.1. Marketing Strategy
21.3.1.6.2. Product Strategy
21.3.1.6.3. Channel Strategy
21.3.2. Ambion, Inc.
21.3.2.1. Overview
21.3.2.2. Product Portfolio
21.3.2.3. Sales Footprint
21.3.2.4. Key Financials
21.3.2.5. SWOT Analysis
21.3.2.6. Strategy Overview
21.3.2.6.1. Marketing Strategy
21.3.2.6.2. Product Strategy
21.3.2.6.3. Channel Strategy
21.3.3. Applera Corporation
21.3.3.1. Overview
21.3.3.2. Product Portfolio
21.3.3.3. Sales Footprint
21.3.3.4. Key Financials
21.3.3.5. SWOT Analysis
21.3.3.6. Strategy Overview
21.3.3.6.1. Marketing Strategy
21.3.3.6.2. Product Strategy
21.3.3.6.3. Channel Strategy
21.3.4. Cenetron Diagnostics
21.3.4.1. Overview
21.3.4.2. Product Portfolio
21.3.4.3. Sales Footprint
21.3.4.4. Key Financials
21.3.4.5. SWOT Analysis
21.3.4.6. Strategy Overview
21.3.4.6.1. Marketing Strategy
21.3.4.6.2. Product Strategy
21.3.4.6.3. Channel Strategy
21.3.5. Cepheid, Inc.
21.3.5.1. Overview
21.3.5.2. Product Portfolio
21.3.5.3. Sales Footprint
21.3.5.4. Key Financials
21.3.5.5. SWOT Analysis
21.3.5.6. Strategy Overview
21.3.5.6.1. Marketing Strategy
21.3.5.6.2. Product Strategy
21.3.5.6.3. Channel Strategy
21.3.6. Chiron Corporation
21.3.6.1. Overview
21.3.6.2. Product Portfolio
21.3.6.3. Sales Footprint
21.3.6.4. Key Financials
21.3.6.5. SWOT Analysis
21.3.6.6. Strategy Overview
21.3.6.6.1. Marketing Strategy
21.3.6.6.2. Product Strategy
21.3.6.6.3. Channel Strategy
21.3.7. Dharmacon, Inc.
21.3.7.1. Overview
21.3.7.2. Product Portfolio
21.3.7.3. Sales Footprint
21.3.7.4. Key Financials
21.3.7.5. SWOT Analysis
21.3.7.6. Strategy Overview
21.3.7.6.1. Marketing Strategy
21.3.7.6.2. Product Strategy
21.3.7.6.3. Channel Strategy
21.3.8. Digene Corporation
21.3.8.1. Overview
21.3.8.2. Product Portfolio
21.3.8.3. Sales Footprint
21.3.8.4. Key Financials
21.3.8.5. SWOT Analysis
21.3.8.6. Strategy Overview
21.3.8.6.1. Marketing Strategy
21.3.8.6.2. Product Strategy
21.3.8.6.3. Channel Strategy
21.3.9. Gen-Probe Incorporated
21.3.9.1. Overview
21.3.9.2. Product Portfolio
21.3.9.3. Sales Footprint
21.3.9.4. Key Financials
21.3.9.5. SWOT Analysis
21.3.9.6. Strategy Overview
21.3.9.6.1. Marketing Strategy
21.3.9.6.2. Product Strategy
21.3.9.6.3. Channel Strategy
21.3.10. Innogenetics NV
21.3.10.1. Overview
21.3.10.2. Product Portfolio
21.3.10.3. Sales Footprint
21.3.10.4. Key Financials
21.3.10.5. SWOT Analysis
21.3.10.6. Strategy Overview
21.3.10.6.1. Marketing Strategy
21.3.10.6.2. Product Strategy
21.3.10.6.3. Channel Strategy
21.3.11. Nanogen, Inc.
21.3.11.1. Overview
21.3.11.2. Product Portfolio
21.3.11.3. Sales Footprint
21.3.11.4. Key Financials
21.3.11.5. SWOT Analysis
21.3.11.6. Strategy Overview
21.3.11.6.1. Marketing Strategy
21.3.11.6.2. Product Strategy
21.3.11.6.3. Channel Strategy
21.3.12. F. Hoffmann-La Roche Ltd
21.3.12.1. Overview
21.3.12.2. Product Portfolio
21.3.12.3. Sales Footprint
21.3.12.4. Key Financials
21.3.12.5. SWOT Analysis
21.3.12.6. Strategy Overview
21.3.12.6.1. Marketing Strategy
21.3.12.6.2. Product Strategy
21.3.12.6.3. Channel Strategy
21.3.13. Becton, Dickinson and Company
21.3.13.1. Overview
21.3.13.2. Product Portfolio
21.3.13.3. Sales Footprint
21.3.13.4. Key Financials
21.3.13.5. SWOT Analysis
21.3.13.6. Strategy Overview
21.3.13.6.1. Marketing Strategy
21.3.13.6.2. Product Strategy
21.3.13.6.3. Channel Strategy
21.3.14. bioMérieux SA
21.3.14.1. Overview
21.3.14.2. Product Portfolio
21.3.14.3. Sales Footprint
21.3.14.4. Key Financials
21.3.14.5. SWOT Analysis
21.3.14.6. Strategy Overview
21.3.14.6.1. Marketing Strategy
21.3.14.6.2. Product Strategy
21.3.14.6.3. Channel Strategy
21.3.15. Hologic, Inc.
21.3.15.1. Overview
21.3.15.2. Product Portfolio
21.3.15.3. Sales Footprint
21.3.15.4. Key Financials
21.3.15.5. SWOT Analysis
21.3.15.6. Strategy Overview
21.3.15.6.1. Marketing Strategy
21.3.15.6.2. Product Strategy
21.3.15.6.3. Channel Strategy
21.3.16. QIAGEN
21.3.16.1. Overview
21.3.16.2. Product Portfolio
21.3.16.3. Sales Footprint
21.3.16.4. Key Financials
21.3.16.5. SWOT Analysis
21.3.16.6. Strategy Overview
21.3.16.6.1. Marketing Strategy
21.3.16.6.2. Product Strategy
21.3.16.6.3. Channel Strategy
21.3.17. Myriad Genetics, Inc.
21.3.17.1. Overview
21.3.17.2. Product Portfolio
21.3.17.3. Sales Footprint
21.3.17.4. Key Financials
21.3.17.5. SWOT Analysis
21.3.17.6. Strategy Overview
21.3.17.6.1. Marketing Strategy
21.3.17.6.2. Product Strategy
21.3.17.6.3. Channel Strategy
21.3.18. Thermo Fisher Scientific
21.3.18.1. Overview
21.3.18.2. Product Portfolio
21.3.18.3. Sales Footprint
21.3.18.4. Key Financials
21.3.18.5. SWOT Analysis
21.3.18.6. Strategy Overview
21.3.18.6.1. Marketing Strategy
21.3.18.6.2. Product Strategy
21.3.18.6.3. Channel Strategy
21.3.19. Meridian Bioscience, Inc.
21.3.19.1. Overview
21.3.19.2. Product Portfolio
21.3.19.3. Sales Footprint
21.3.19.4. Key Financials
21.3.19.5. SWOT Analysis
21.3.19.6. Strategy Overview
21.3.19.6.1. Marketing Strategy
21.3.19.6.2. Product Strategy
21.3.19.6.3. Channel Strategy
22. Assumptions and Acronyms Used
23. Research Methodology
Table 01: Global Infectious Disease Diagnostic Market Size (US$ Bn) Analysis and Forecast 2023–2033, by Product
Table 02: Global Infectious Disease Diagnostic Market Size (US$ Bn) Analysis and Forecast 2023–2033, by Test Type
Table 03: Global Infectious Disease Diagnostic Market Size (US$ Bn) Analysis and Forecast 2023–2033, by Application
Table 04: Global Infectious Disease Diagnostic Market Value (US$ Bn) Analysis- and Forecast 2023–2033, by End User
Table 05: North America Infectious Disease Diagnostic Market Size Analysis 2013–2022 and Forecast 2023–2033, by Country
Table 06: North America Infectious Disease Diagnostic Market Size Analysis 2013–2022 and Forecast 2023–2033, by Product
Table 07: North America Infectious Disease Diagnostic Market Size Analysis 2013–2022 and Forecast 2023–2033, by Test Type
Table 08: North America Infectious Disease Diagnostic Market Size Analysis 2013–2022 and Forecast 2023–2033, by Application
Table 09: North America Infectious Disease Diagnostic Market Size Analysis 2013–2022 and Forecast 2023–2033, by End User
Table 10: Latin America Infectious Disease Diagnostic Market Size Analysis 2013–2022 and Forecast 2023–2033, by Country
Table 11: Latin America Infectious Disease Diagnostic Market Size Analysis 2013–2022 and Forecast 2023–2033, by Product
Table 12: Latin America Infectious Disease Diagnostic Market Size Analysis 2013–2022 and Forecast 2023–2033, by Test Type
Table 13: Latin America Infectious Disease Diagnostic Market Size Analysis 2013–2022 and Forecast 2023–2033, by Application
Table 14: Latin America Infectious Disease Diagnostic Market Size Analysis 2013–2022 and Forecast 2023–2033, by End User
Table 15: Europe Infectious Disease Diagnostic Market Size Analysis 2013–2022 and Forecast 2023–2033, by Country
Table 16: Europe Infectious Disease Diagnostic Market Size Analysis 2013–2022 and Forecast 2023–2033, by Product
Table 17: Europe Infectious Disease Diagnostic Market Size Analysis 2013–2022 and Forecast 2023–2033, by Test Type
Table 18: Europe Infectious Disease Diagnostic Market Size Analysis 2013–2022 and Forecast 2023–2033, by Application
Table 19: Europe Infectious Disease Diagnostic Market Size Analysis 2013–2022 and Forecast 2023–2033, by End User
Table 20: South Asia Infectious Disease Diagnostic Market Size Analysis 2013–2022 and Forecast 2023–2033, by Country
Table 21: South Asia Infectious Disease Diagnostic Market Size Analysis 2013–2022 and Forecast 2023–2033, by Product
Table 22: South Asia Infectious Disease Diagnostic Market Size Analysis 2013–2022 and Forecast 2023–2033, by Test Type
Table 23: South Asia Infectious Disease Diagnostic Market Size Analysis 2013–2022 and Forecast 2023–2033, by Application
Table 24: South Asia Infectious Disease Diagnostic Market Size Analysis 2013–2022 and Forecast 2023–2033, by End User
Table 25: East Asia Infectious Disease Diagnostic Market Size Analysis 2013–2022 and Forecast 2023–2033, by Country
Table 26: East Asia Infectious Disease Diagnostic Market Size Analysis 2013–2022 and Forecast 2023–2033, by Product
Table 27: East Asia Infectious Disease Diagnostic Market Size Analysis 2013–2022 and Forecast 2023–2033, by Test Type
Table 28: East Asia Infectious Disease Diagnostic Market Size Analysis 2013–2022 and Forecast 2023–2033, by Application
Table 29: East Asia Infectious Disease Diagnostic Market Size Analysis 2013–2022 and Forecast 2023–2033, by End User
Table 30: Oceania Infectious Disease Diagnostic Market Size Analysis 2013–2022 and Forecast 2023–2033, by Country
Table 31: Oceania Infectious Disease Diagnostic Market Size Analysis 2013–2022 and Forecast 2023–2033, by Product
Table 32: Oceania Infectious Disease Diagnostic Market Size Analysis 2013–2022 and Forecast 2023–2033, by Test Type
Table 33: Oceania Infectious Disease Diagnostic Market Size Analysis 2013–2022 and Forecast 2023–2033, by Application
Table 34: Oceania Infectious Disease Diagnostic Market Size Analysis 2013–2022 and Forecast 2023–2033, by End User
Table 35: Middle East & Africa Infectious Disease Diagnostic Market Size Analysis 2013–2022 and Forecast 2023–2033, by Country
Table 36: Middle East & Africa Infectious Disease Diagnostic Market Size Analysis 2013–2022 and Forecast 2023–2033, by Product
Table 37: Middle East & Africa Infectious Disease Diagnostic Market Size Analysis 2013–2022 and Forecast 2023–2033, by Test Type
Table 38: Middle East & Africa Infectious Disease Diagnostic Market Size Analysis 2013–2022 and Forecast 2023–2033, by Application
Table 39: Middle East & Africa Infectious Disease Diagnostic Market Size Analysis 2013–2022 and Forecast 2023–2033, by End User
Figure 01: Global Infectious Disease Diagnostic Market Value Analysis (US$ Bn), 2013–2022
Figure 02: Global Infectious Disease Diagnostic Market Value Forecast (US$ Bn), 2022-2033
Figure 03: Global Infectious Disease Diagnostic Market Absolute $ Opportunity, 2022 - 2033
Figure 04: Global Infectious Disease Diagnostic Market Share Analysis (%), by Product, 2023 & 2033
Figure 05: Global Infectious Disease Diagnostic Market Y-o-Y Analysis (%), by Product, 2023-2033
Figure 06: Global Infectious Disease Diagnostic Market Attractiveness Analysis by Product, 2023-2033
Figure 07: Global Infectious Disease Diagnostic Market Share Analysis (%), by Test Type, 2023 & 2033
Figure 08: Global Infectious Disease Diagnostic Market Y-o-Y Analysis (%), by Test Type, 2023-2033
Figure 09: Global Infectious Disease Diagnostic Market Attractiveness Analysis by Test Type, 2023-2033
Figure 10: Global Infectious Disease Diagnostic Market Share Analysis (%), by Application, 2023 & 2033
Figure 11: Global Infectious Disease Diagnostic Market Y-o-Y Analysis (%), by Application, 2023-2033
Figure 12: Global Infectious Disease Diagnostic Market Attractiveness Analysis by Application, 2023-2033
Figure 13: Global Infectious Disease Diagnostic Market Share Analysis (%), End User, 2023 & 2033
Figure 14: Global Infectious Disease Diagnostic Market Y-o-Y Analysis (%), End User, 2023-2033
Figure 15: Global Infectious Disease Diagnostic Market Attractiveness Analysis End User, 2023-2033
Figure 16: North America Infectious Disease Diagnostic Market Value Share by Product 2023 (E)
Figure 17: North America Infectious Disease Diagnostic Market Value Share by Test Type 2023 (E)
Figure 18: North America Infectious Disease Diagnostic Market Value Share by Application 2023 (E)
Figure 19: North America Infectious Disease Diagnostic Market Value Share End User 2023 (E)
Figure 20: North America Infectious Disease Diagnostic Market Value Share by Country 2023 (E)
Figure 21: North America Market Historical Market Size (US$ Bn) Analysis, 2013–2022
Figure 22: North America Market Current and Future Market Size (US$ Bn), 2022-2033 & Y-o-Y Growth Trend Analysis
Figure 23: North America Infectious Disease Diagnostic Market Attractiveness Analysis by Product, 2023-2033
Figure 24: North America Infectious Disease Diagnostic Market Attractiveness Analysis by Test Type, 2023-2033
Figure 25: North America Infectious Disease Diagnostic Market Attractiveness Analysis by Application, 2023-2033
Figure 26: North America Infectious Disease Diagnostic Market Attractiveness Analysis End User, 2023-2033
Figure 27: North America Infectious Disease Diagnostic Market Attractiveness Analysis by Country, 2023-2033
Figure 28: U.S. Infectious Disease Diagnostic Market Value Proportion Analysis, 2022
Figure 29: U.S. Infectious Disease Diagnostic Market Share Analysis (%), by Product, 2022 & 2033
Figure 30: U.S. Infectious Disease Diagnostic Market Share Analysis (%), by Test Type, 2022 & 2033
Figure 31: U.S. Infectious Disease Diagnostic Market Share Analysis (%), by Application, 2022 & 2033
Figure 32: U.S. Infectious Disease Diagnostic Market Share Analysis (%), End User, 2022 & 2033
Figure 33: Canada Infectious Disease Diagnostic Market Value Proportion Analysis, 2022
Figure 34: Canada Infectious Disease Diagnostic Market Share Analysis (%), by Product, 2022 & 2033
Figure 35: Canada Infectious Disease Diagnostic Market Share Analysis (%), by Test Type, 2022 & 2033
Figure 36: Canada Infectious Disease Diagnostic Market Share Analysis (%), by Application, 2022 & 2033
Figure 37: Canada Infectious Disease Diagnostic Market Share Analysis (%), End User, 2022 & 2033
Figure 38: Latin America Infectious Disease Diagnostic Market Value Share by Product 2023 (E)
Figure 39: Latin America Infectious Disease Diagnostic Market Value Share by Test Type 2023 (E)
Figure 40: Latin America Infectious Disease Diagnostic Market Value Share by Application 2023 (E)
Figure 41: Latin America Infectious Disease Diagnostic Market Value Share End User 2023 (E)
Figure 42: Latin America Infectious Disease Diagnostic Market Value Share by Country 2023 (E)
Figure 43: Latin America Market Historical Market Size (US$ Bn) Analysis, 2013–2022
Figure 44: Latin America Market Current and Future Market Size (US$ Bn), 2022-2033 & Y-o-Y Growth Trend Analysis
Figure 45: Latin America Infectious Disease Diagnostic Market Attractiveness Analysis by Product, 2023-2033
Figure 46: Latin America Infectious Disease Diagnostic Market Attractiveness Analysis by Test Type, 2023-2033
Figure 47: Latin America Infectious Disease Diagnostic Market Attractiveness Analysis by Application, 2023-2033
Figure 48: Latin America Infectious Disease Diagnostic Market Attractiveness Analysis End User, 2023-2033
Figure 49: Latin America Infectious Disease Diagnostic Market Attractiveness Analysis by Country, 2023-2033
Figure 50: Brazil Infectious Disease Diagnostic Market Value Proportion Analysis, 2022
Figure 51: Brazil Infectious Disease Diagnostic Market Share Analysis (%), by Product, 2022 & 2033
Figure 52: Brazil Infectious Disease Diagnostic Market Share Analysis (%), by Test Type, 2022 & 2033
Figure 53: Brazil Infectious Disease Diagnostic Market Share Analysis (%), by Application, 2022 & 2033
Figure 54: Brazil Infectious Disease Diagnostic Market Share Analysis (%), End User, 2022 & 2033
Figure 55: Mexico Infectious Disease Diagnostic Market Value Proportion Analysis, 2022
Figure 56: Mexico Infectious Disease Diagnostic Market Share Analysis (%), by Product, 2022 & 2033
Figure 57: Mexico Infectious Disease Diagnostic Market Share Analysis (%), by Test Type, 2022 & 2033
Figure 58: Mexico Infectious Disease Diagnostic Market Share Analysis (%), by Application, 2022 & 2033
Figure 59: Mexico Infectious Disease Diagnostic Market Share Analysis (%), End User, 2022 & 2033
Figure 60: Argentina Infectious Disease Diagnostic Market Value Proportion Analysis, 2022
Figure 61: Argentina Infectious Disease Diagnostic Market Share Analysis (%), by Product, 2022 & 2033
Figure 62: Argentina Infectious Disease Diagnostic Market Share Analysis (%), by Test Type, 2022 & 2033
Figure 63: Argentina Infectious Disease Diagnostic Market Share Analysis (%), by Application, 2022 & 2033
Figure 64: Argentina Infectious Disease Diagnostic Market Share Analysis (%), End User, 2022 & 2033
Figure 65: Europe Infectious Disease Diagnostic Market Value Share by Product 2023 (E)
Figure 66: Europe Infectious Disease Diagnostic Market Value Share by Test Type 2023 (E)
Figure 67: Europe Infectious Disease Diagnostic Market Value Share by Application 2023 (E)
Figure 68: Europe Infectious Disease Diagnostic Market Value Share End User 2023 (E)
Figure 69: Europe Infectious Disease Diagnostic Market Value Share by Country 2023 (E)
Figure 70: Europe Market Historical Market Size (US$ Bn) Analysis, 2013–2022
Figure 71: Europe Market Current and Future Market Size (US$ Bn), 2022-2033 & Y-o-Y Growth Trend Analysis
Figure 72: Europe Infectious Disease Diagnostic Market Attractiveness Analysis by Product, 2023-2033
Figure 73: Europe Infectious Disease Diagnostic Market Attractiveness Analysis by Test Type, 2023-2033
Figure 74: Europe Infectious Disease Diagnostic Market Attractiveness Analysis by Application, 2023-2033
Figure 75: Europe Infectious Disease Diagnostic Market Attractiveness Analysis End User, 2023-2033
Figure 76: Europe Infectious Disease Diagnostic Market Attractiveness Analysis by Country, 2023-2033
Figure 77: Italy Infectious Disease Diagnostic Market Value Proportion Analysis, 2022
Figure 78: Italy Infectious Disease Diagnostic Market Share Analysis (%), by Product, 2022 & 2033
Figure 79: Italy Infectious Disease Diagnostic Market Share Analysis (%), by Test Type, 2022 & 2033
Figure 80: Italy Infectious Disease Diagnostic Market Share Analysis (%), by Application, 2022 & 2033
Figure 81: Italy Infectious Disease Diagnostic Market Share Analysis (%), End User, 2022 & 2033
Figure 82: Germany Infectious Disease Diagnostic Market Value Proportion Analysis, 2022
Figure 83: Germany Infectious Disease Diagnostic Market Share Analysis (%), by Product, 2022 & 2033
Figure 84: Germany Infectious Disease Diagnostic Market Share Analysis (%), by Test Type, 2022 & 2033
Figure 85: Germany Infectious Disease Diagnostic Market Share Analysis (%), by Application, 2022 & 2033
Figure 86: Germany Infectious Disease Diagnostic Market Share Analysis (%), End User, 2022 & 2033
Figure 87: U.K. Infectious Disease Diagnostic Market Value Proportion Analysis, 2022
Figure 88: U.K. Infectious Disease Diagnostic Market Share Analysis (%), by Product, 2022 & 2033
Figure 89: U.K. Infectious Disease Diagnostic Market Share Analysis (%), by Test Type, 2022 & 2033
Figure 90: U.K. Infectious Disease Diagnostic Market Share Analysis (%), by Application, 2022 & 2033
Figure 91: U.K. Infectious Disease Diagnostic Market Share Analysis (%), End User, 2022 & 2033
Figure 92: France Infectious Disease Diagnostic Market Value Proportion Analysis, 2022
Figure 93: France Infectious Disease Diagnostic Market Share Analysis (%), by Product, 2022 & 2033
Figure 94: France Infectious Disease Diagnostic Market Share Analysis (%), by Test Type, 2022 & 2033
Figure 95: France Infectious Disease Diagnostic Market Share Analysis (%), by Application, 2022 & 2033
Figure 96: France Infectious Disease Diagnostic Market Share Analysis (%), End User, 2022 & 2033
Figure 97: Spain Infectious Disease Diagnostic Market Value Proportion Analysis, 2022
Figure 98: Spain Infectious Disease Diagnostic Market Share Analysis (%), by Product, 2022 & 2033
Figure 99: Spain Infectious Disease Diagnostic Market Share Analysis (%), by Test Type, 2022 & 2033
Figure 100: Spain Infectious Disease Diagnostic Market Share Analysis (%), by Application, 2022 & 2033
Figure 101: Spain Infectious Disease Diagnostic Market Share Analysis (%), End User, 2022 & 2033
Figure 102: BENELUX Infectious Disease Diagnostic Market Value Proportion Analysis, 2022
Figure 103: BENELUX Infectious Disease Diagnostic Market Share Analysis (%), by Product, 2022 & 2033
Figure 104: BENELUX Infectious Disease Diagnostic Market Share Analysis (%), by Test Type, 2022 & 2033
Figure 105: BENELUX Infectious Disease Diagnostic Market Share Analysis (%), by Application, 2022 & 2033
Figure 106: BENELUX Infectious Disease Diagnostic Market Share Analysis (%), End User, 2022 & 2033
Figure 107: Nordic Countries Infectious Disease Diagnostic Market Value Proportion Analysis, 2022
Figure 108: Nordic Countries Infectious Disease Diagnostic Market Share Analysis (%), by Product, 2022 & 2033
Figure 109: Nordic Countries Infectious Disease Diagnostic Market Share Analysis (%), by Test Type, 2022 & 2033
Figure 110: Nordic Countries Infectious Disease Diagnostic Market Share Analysis (%), by Application, 2022 & 2033
Figure 111: Nordic Countries Infectious Disease Diagnostic Market Share Analysis (%), End User, 2022 & 2033
Figure 112: Russia Infectious Disease Diagnostic Market Value Proportion Analysis, 2022
Figure 113: Russia Infectious Disease Diagnostic Market Share Analysis (%), by Product, 2022 & 2033
Figure 114: Russia Infectious Disease Diagnostic Market Share Analysis (%), by Test Type, 2022 & 2033
Figure 115: Russia Infectious Disease Diagnostic Market Share Analysis (%), by Application, 2022 & 2033
Figure 116: Russia Infectious Disease Diagnostic Market Share Analysis (%), End User, 2022 & 2033
Figure 117: South Asia Infectious Disease Diagnostic Market Value Share by Product 2023 (E)
Figure 118: South Asia Infectious Disease Diagnostic Market Value Share by Test Type 2023 (E)
Figure 119: South Asia Infectious Disease Diagnostic Market Value Share by Application 2023 (E)
Figure 120: South Asia Infectious Disease Diagnostic Market Value Share End User 2023 (E)
Figure 121: South Asia Infectious Disease Diagnostic Market Value Share by Country 2023 (E)
Figure 122: South Asia Market Historical Market Size (US$ Bn) Analysis, 2013–2022
Figure 123: South Asia Market Current and Future Market Size (US$ Bn), 2022-2033 & Y-o-Y Growth Trend Analysis
Figure 124: South Asia Infectious Disease Diagnostic Market Attractiveness Analysis by Product, 2023-2033
Figure 125: South Asia Infectious Disease Diagnostic Market Attractiveness Analysis by Test Type, 2023-2033
Figure 126: South Asia Infectious Disease Diagnostic Market Attractiveness Analysis by Application, 2023-2033
Figure 127: South Asia Infectious Disease Diagnostic Market Attractiveness Analysis End User, 2023-2033
Figure 128: South Asia Infectious Disease Diagnostic Market Attractiveness Analysis by Country, 2023-2033
Figure 129: India Infectious Disease Diagnostic Market Value Proportion Analysis, 2022
Figure 130: India Infectious Disease Diagnostic Market Share Analysis (%), by Product, 2022 & 2033
Figure 131: India Infectious Disease Diagnostic Market Share Analysis (%), by Test Type, 2022 & 2033
Figure 132: India Infectious Disease Diagnostic Market Share Analysis (%), by Application, 2022 & 2033
Figure 133: India Infectious Disease Diagnostic Market Share Analysis (%), End User, 2022 & 2033
Figure 134: Thailand Infectious Disease Diagnostic Market Value Proportion Analysis, 2022
Figure 135: Thailand Infectious Disease Diagnostic Market Share Analysis (%), by Product, 2022 & 2033
Figure 136: Thailand Infectious Disease Diagnostic Market Share Analysis (%), by Test Type, 2022 & 2033
Figure 137: Thailand Infectious Disease Diagnostic Market Share Analysis (%), by Application, 2022 & 2033
Figure 138: Thailand Infectious Disease Diagnostic Market Share Analysis (%), End User, 2022 & 2033
Figure 139: Indonesia Infectious Disease Diagnostic Market Value Proportion Analysis, 2022
Figure 140: Indonesia Infectious Disease Diagnostic Market Share Analysis (%), by Product, 2022 & 2033
Figure 141: Indonesia Infectious Disease Diagnostic Market Share Analysis (%), by Test Type, 2022 & 2033
Figure 142: Indonesia Infectious Disease Diagnostic Market Share Analysis (%), by Application, 2022 & 2033
Figure 143: Indonesia Infectious Disease Diagnostic Market Share Analysis (%), End User, 2022 & 2033
Figure 144: Malaysia Infectious Disease Diagnostic Market Value Proportion Analysis, 2022
Figure 145: Malaysia Infectious Disease Diagnostic Market Share Analysis (%), by Product, 2022 & 2033
Figure 146: Malaysia Infectious Disease Diagnostic Market Share Analysis (%), by Test Type, 2022 & 2033
Figure 147: Malaysia Infectious Disease Diagnostic Market Share Analysis (%), by Application, 2022 & 2033
Figure 148: Malaysia Infectious Disease Diagnostic Market Share Analysis (%), End User, 2022 & 2033
Figure 149: East Asia Infectious Disease Diagnostic Market Value Share by Product 2023 (E)
Figure 150: East Asia Infectious Disease Diagnostic Market Value Share by Test Type 2023 (E)
Figure 151: East Asia Infectious Disease Diagnostic Market Value Share by Application 2023 (E)
Figure 152: East Asia Infectious Disease Diagnostic Market Value Share End User 2023 (E)
Figure 153: East Asia Infectious Disease Diagnostic Market Value Share by Country 2023 (E)
Figure 154: East Asia Market Historical Market Size (US$ Bn) Analysis, 2013–2022
Figure 155: East Asia Market Current and Future Market Size (US$ Bn), 2022-2033 & Y-o-Y Growth Trend Analysis
Figure 156: East Asia Infectious Disease Diagnostic Market Attractiveness Analysis by Product, 2023-2033
Figure 157: East Asia Infectious Disease Diagnostic Market Attractiveness Analysis by Test Type, 2023-2033
Figure 158: East Asia Infectious Disease Diagnostic Market Attractiveness Analysis by Application, 2023-2033
Figure 159: East Asia Infectious Disease Diagnostic Market Attractiveness Analysis End User, 2023-2033
Figure 160: East Asia Infectious Disease Diagnostic Market Attractiveness Analysis by Country, 2023-2033
Figure 161: China Infectious Disease Diagnostic Market Value Proportion Analysis, 2022
Figure 162: China Infectious Disease Diagnostic Market Share Analysis (%), by Product, 2022 & 2033
Figure 163: China Infectious Disease Diagnostic Market Share Analysis (%), by Test Type, 2022 & 2033
Figure 164: China Infectious Disease Diagnostic Market Share Analysis (%), by Application, 2022 & 2033
Figure 165: China Infectious Disease Diagnostic Market Share Analysis (%), End User, 2022 & 2033
Figure 166: Japan Infectious Disease Diagnostic Market Value Proportion Analysis, 2022
Figure 167: Japan Infectious Disease Diagnostic Market Share Analysis (%), by Product, 2022 & 2033
Figure 168: Japan Infectious Disease Diagnostic Market Share Analysis (%), by Test Type, 2022 & 2033
Figure 169: Japan Infectious Disease Diagnostic Market Share Analysis (%), by Application, 2022 & 2033
Figure 170: Japan Infectious Disease Diagnostic Market Share Analysis (%), End User, 2022 & 2033
Figure 171: South Korea Infectious Disease Diagnostic Market Value Proportion Analysis, 2022
Figure 172: South Korea Infectious Disease Diagnostic Market Share Analysis (%), by Product, 2022 & 2033
Figure 173: South Korea Infectious Disease Diagnostic Market Share Analysis (%), by Test Type, 2022 & 2033
Figure 174: South Korea Infectious Disease Diagnostic Market Share Analysis (%), by Application, 2022 & 2033
Figure 175: South Korea Infectious Disease Diagnostic Market Share Analysis (%), End User, 2022 & 2033
Figure 176: Oceania Infectious Disease Diagnostic Market Value Share by Product 2023 (E)
Figure 177: Oceania Infectious Disease Diagnostic Market Value Share by Test Type 2023 (E)
Figure 178: Oceania Infectious Disease Diagnostic Market Value Share by Application 2023 (E)
Figure 179: Oceania Infectious Disease Diagnostic Market Value Share End User 2023 (E)
Figure 180: Oceania Infectious Disease Diagnostic Market Value Share by Country 2023 (E)
Figure 181: Oceania Market Historical Market Size (US$ Bn) Analysis, 2013–2022
Figure 182: Oceania Market Current and Future Market Size (US$ Bn), 2022-2033 & Y-o-Y Growth Trend Analysis
Figure 183: Oceania Infectious Disease Diagnostic Market Attractiveness Analysis by Product, 2023-2033
Figure 184: Oceania Infectious Disease Diagnostic Market Attractiveness Analysis by Test Type, 2023-2033
Figure 185: Oceania Infectious Disease Diagnostic Market Attractiveness Analysis by Application, 2023-2033
Figure 186: Oceania Infectious Disease Diagnostic Market Attractiveness Analysis End User, 2023-2033
Figure 187: Oceania Infectious Disease Diagnostic Market Attractiveness Analysis by Country, 2023-2033
Figure 188: Australia Infectious Disease Diagnostic Market Value Proportion Analysis, 2022
Figure 189: Australia Infectious Disease Diagnostic Market Share Analysis (%), by Product, 2022 & 2033
Figure 190: Australia Infectious Disease Diagnostic Market Share Analysis (%), by Test Type, 2022 & 2033
Figure 191: Australia Infectious Disease Diagnostic Market Share Analysis (%), by Application, 2022 & 2033
Figure 192: Australia Infectious Disease Diagnostic Market Share Analysis (%), End User, 2022 & 2033
Figure 193: New Zealand Infectious Disease Diagnostic Market Value Proportion Analysis, 2022
Figure 194: New Zealand Infectious Disease Diagnostic Market Share Analysis (%), by Product, 2022 & 2033
Figure 195: New Zealand Infectious Disease Diagnostic Market Share Analysis (%), by Test Type, 2022 & 2033
Figure 196: New Zealand Infectious Disease Diagnostic Market Share Analysis (%), by Application, 2022 & 2033
Figure 197: New Zealand Infectious Disease Diagnostic Market Share Analysis (%), End User, 2022 & 2033
Figure 198: Middle East & Africa Infectious Disease Diagnostic Market Value Share by Product 2023 (E)
Figure 199: Middle East & Africa Infectious Disease Diagnostic Market Value Share by Test Type 2023 (E)
Figure 200: Middle East & Africa Infectious Disease Diagnostic Market Value Share by Application 2023 (E)
Figure 201: Middle East & Africa Infectious Disease Diagnostic Market Value Share End User 2023 (E)
Figure 202: Middle East & Africa Infectious Disease Diagnostic Market Value Share by Country 2023 (E)
Figure 203: Middle East & Africa Market Historical Market Size (US$ Bn) Analysis, 2013–2022
Figure 204: Middle East & Africa Market Current and Future Market Size (US$ Bn), 2022-2033 & Y-o-Y Growth Trend Analysis
Figure 205: Middle East & Africa Infectious Disease Diagnostic Market Attractiveness Analysis by Product, 2023-2033
Figure 206: Middle East & Africa Infectious Disease Diagnostic Market Attractiveness Analysis by Test Type, 2023-2033
Figure 207: Middle East & Africa Infectious Disease Diagnostic Market Attractiveness Analysis by Application, 2023-2033
Figure 208: Middle East & Africa Infectious Disease Diagnostic Market Attractiveness Analysis End User, 2023-2033
Figure 209: Middle East & Africa Infectious Disease Diagnostic Market Attractiveness Analysis by Country, 2023-2033
Figure 210: GCC Countries Infectious Disease Diagnostic Market Value Proportion Analysis, 2022
Figure 211: GCC Countries Infectious Disease Diagnostic Market Share Analysis (%), by Product, 2022 & 2033
Figure 212: GCC Countries Infectious Disease Diagnostic Market Share Analysis (%), by Test Type, 2022 & 2033
Figure 213: GCC Countries Infectious Disease Diagnostic Market Share Analysis (%), by Application, 2022 & 2033
Figure 214: GCC Countries Infectious Disease Diagnostic Market Share Analysis (%), End User, 2022 & 2033
Figure 215: South Africa Infectious Disease Diagnostic Market Value Proportion Analysis, 2022
Figure 216: South Africa Infectious Disease Diagnostic Market Share Analysis (%), by Product, 2022 & 2033
Figure 217: South Africa Infectious Disease Diagnostic Market Share Analysis (%), by Test Type, 2022 & 2033
Figure 218: South Africa Infectious Disease Diagnostic Market Share Analysis (%), by Application, 2022 & 2033
Figure 219: South Africa Infectious Disease Diagnostic Market Share Analysis (%), End User, 2022 & 2033
Figure 220: North Africa Infectious Disease Diagnostic Market Value Proportion Analysis, 2022
Figure 221: North Africa Infectious Disease Diagnostic Market Share Analysis (%), by Product, 2022 & 2033
Figure 222: North Africa Infectious Disease Diagnostic Market Share Analysis (%), by Test Type, 2022 & 2033
Figure 223: North Africa Infectious Disease Diagnostic Market Share Analysis (%), by Application, 2022 & 2033
Figure 224: North Africa Infectious Disease Diagnostic Market Share Analysis (%), End User, 2022 & 2033
Figure 225: Türkiye Infectious Disease Diagnostic Market Value Proportion Analysis, 2022
Figure 226: Türkiye Infectious Disease Diagnostic Market Share Analysis (%), by Product, 2022 & 2033
Figure 227: Türkiye Infectious Disease Diagnostic Market Share Analysis (%), by Test Type, 2022 & 2033
Figure 228: Türkiye Infectious Disease Diagnostic Market Share Analysis (%), by Application, 2022 & 2033
Figure 229: Türkiye Infectious Disease Diagnostic Market Share Analysis (%), End User, 2022 & 2033